Deskripsi
Short-chain fatty acid concentrations in fecal samples are compared across groups, showing altered microbial metabolite production following BL-99 treatment.
Figure 6
ChartSource Paper
Bifidobacterium lactis BL-99 modulates intestinal inflammation and functions in zebrafish models.Cite This Figure
![Figure 6: Short-chain fatty acid concentrations in fecal samples are compared across groups, showing altered microbial metabolite production following BL-99 treatment.]() > Source: Meng Chen et al. "Bifidobacterium lactis BL-99 modulates intestinal inflammation and functions in ." *PloS one*, 2022. PMID: [35171916](https://pubmed.ncbi.nlm.nih.gov/35171916/)
<figure> <img src="" alt="Short-chain fatty acid concentrations in fecal samples are compared across groups, showing altered microbial metabolite production following BL-99 treatment." /> <figcaption>Figure 6. Short-chain fatty acid concentrations in fecal samples are compared across groups, showing altered microbial metabolite production following BL-99 treatment.<br> Source: Meng Chen et al. "Bifidobacterium lactis BL-99 modulates intestinal inflammation and functions in ." <em>PloS one</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35171916/">35171916</a></figcaption> </figure>